Similar articles

• [Cellular immunity and the autoantibody system in polymyositis and dermatomyositis].

  Ljubicić N, Cikes N. Ljubicić N, et al. Lijec Vjesn. 1991 Mar-Apr;113(3-4):95-9. Lijec Vjesn. 1991. PMID: 1890925 Review. Croatian.
• Autoantibodies in scleroderma and polymyositis: an update.

  McCarty GA. McCarty GA. Semin Dermatol. 1991 Sep;10(3):206-16. Semin Dermatol. 1991. PMID: 1931570 Review.
• [Immunological aspects of polymyositis].

  Takayanagi T, Honda H. Takayanagi T, et al. No To Shinkei. 1983 Jun;35(6):525-33. No To Shinkei. 1983. PMID: 6354219 Review. Japanese. No abstract available.
• Cellular immunity in polymyositis/dermatomyositis.

  Ytterberg SR. Ytterberg SR. Mt Sinai J Med. 1988 Nov;55(6):494-500. Mt Sinai J Med. 1988. PMID: 3068538 Review. No abstract available.
• [Effects of tetramisole in polymyositis and dermatomyositis].

  Devulder B, Plouvier B, Francois M. Devulder B, et al. Nouv Presse Med. 1976 Apr 23;6(17):1480-1. Nouv Presse Med. 1976. PMID: 1025532 French. No abstract available.